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A number of studies have shown that grape extracts exhibit significant anticancer properties, 
which are associated with their polyphenolic content [1, 2]. Most of these studies refer to grape 
skins, juices, seeds and pomace. On the other hand, there are no studies concerning the grape 
stems, a scarcely investigated byproduct produced in large amounts during the vinification 
process, making the exploitation of grape stems an intriguing research target. Main objective of 
this endeavor is the assessment of the polyphenolic content of grape stem extracts derived from 
eight Greek Vitis vinifera varieties and the evaluation of their biological properties through the 
assessment of their effects on liver (HepG2) and cervical (HeLa) cancer cells growth as well as 
the determination of their in-vitro anti-angiogenic properties using the ‘tube formation’ assay.  
 
In particular, the chemical analysis results indicated that the methanolic extracts of grape stems 
are particularly rich in polyphenols (flavonoids, phenolic acids and stilbenes), containing 
noticeable amounts of trans-resveratrol (0,33-25,41 mg/g), quercetin (3,94-18,53 mg/g), catechin 
(2,37-13,75 mg/g), epicatechin (4,51-28,31 mg/g) and ferulic (0,28-11,68 mg/g), gallic (1,52-
42,29 mg/g) and syringic (0,80-32,23 mg/g) acids. Additionally, these extracts were found as 
potent inhibitors of HepG2 (IC50: 34-50 μg/mL) and HeLa (IC50: 15-48 μg/mL) cancer cells 
growth, at IC50 values comparable to those determined for grape seed extracts. Moreover, the 
white variety Asyrtiko Santorini stems extract was found to inhibit the tube formation (a marker 
of angiogenesis) by 63% and 94% respectively, in human EAhy926 cells at non-cytotoxic 
concentrations of 50 and 100 μg/mL. Same extract reduced the expression levels of the main 
angiogenic factor Vascular Endothelial Growth Factor (VEGF), in EAhy926 cells by 39% at 100 
μg/mL, while had no effect on the Hypoxia Inducible Factor-1a (HIF-1a) levels. Thus, the anti-
angiogenic potency of the stem extract may be attributed to their capability to inhibit the VEGF 
through a mechanism that does not involve the HIF-1a.  
Results herein suggest that grape stems extracts may account as a rich source of bioactive 
polyphenols, which display important biological properties. 
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